Atlas Trials

Serum Presepsin as Early Predictor for Neonatal Early-onset Sepsis

Clinical trial NCT05022043 · COMPLETED

Trial details

NCT number
NCT05022043
Sponsor
Tanta University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Neonatal Sepsis
Start date
2019-03-01
Primary completion
2020-12-30
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.